NaoXinTong Capsules inhibit the development of diabetic nephropathy in db/db mice-Reference-Cited by-同舟云学术

NaoXinTong Capsules inhibit the development of diabetic nephropathy in db/db mice

Published:2018-06-14 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Yang Shu,Liu Mengyang,Chen Yuanli,Ma Chuanrui,Liu Lipei,Zhao Buchang,Wang Yong,Li Xiaoju,Zhu Yan,Gao Xiumei,Kong Deling,Duan Yajun,Han Jihong,Yang Xiaoxiao

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-26746-1.pdf

Reference58 articles.

1. Terry, T., Raravikar, K., Chokrungvaranon, N. & Reaven, P. D. Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT. Curr Cardiol Rep. 14, 79–88 (2012).

2. Soetikno, V., Arozal, W., Louisa, M. & Setiabudy, R. New Insight into the Molecular Drug Target of Diabetic Nephropathy. Int J Endocrinol (2014).

3. Rosario, R. F. & Prabhakar, S. Lipids and diabetic nephropathy. Curr Diab Rep. 6, 455–462 (2006).

4. Neugarten, J. & Golestaneh, L. Gender and the Prevalence and Progression of Renal Disease. Adv Chronic Kidney D. 20, 390–395 (2013).

5. Barutta, F., Bruno, G., Grimaldi, S. & Gruden, G. Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment. Endocrine. 48, 730–742 (2015).

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Naoxintong capsule for treating cardiovascular and cerebrovascular diseases: from bench to bedside;Frontiers in Pharmacology;2024-06-27

2. Mechanisms and efficacy of traditional Chinese herb monomers in diabetic kidney disease;International Urology and Nephrology;2023-08-08

3. Naoxintong capsule delay the progression of diabetic kidney disease: A real-world cohort study;Frontiers in Endocrinology;2022-11-03

4. Naoxintong Capsule for Secondary Prevention of Ischemic Stroke: A Multicenter, Randomized, and Placebo-Controlled Trial;Chinese Journal of Integrative Medicine;2022-10-17

5. The Antidiabetic Activities of Neocryptotanshinone: Screened by Molecular Docking and Related to the Modulation of PTP1B;Nutrients;2022-07-24